Biosino Bio-Technology and Science Incorporation (HKG:8247)
Hong Kong
· Delayed Price · Currency is HKD 3.500
0.00 (0.00%)
At close: Apr 29, 2026
HKG:8247 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 184.29 | 263.07 | 289.07 | 373.07 | 348.23 | Upgrade
|
| Revenue Growth (YoY) | -29.95% | -9.00% | -22.52% | 7.13% | 7.06% | Upgrade
|
| Cost of Revenue | 113.37 | 154.67 | 161.71 | 226.79 | 204.63 | Upgrade
|
| Gross Profit | 70.92 | 108.4 | 127.37 | 146.28 | 143.59 | Upgrade
|
| Selling, General & Admin | 93.27 | 106.6 | 110.4 | 99.67 | 93.27 | Upgrade
|
| Research & Development | 26.82 | 33.42 | 35.81 | 26.87 | 24.94 | Upgrade
|
| Operating Expenses | 124.76 | 145.69 | 146.78 | 126.54 | 118.22 | Upgrade
|
| Operating Income | -53.84 | -37.29 | -19.41 | 19.74 | 25.38 | Upgrade
|
| Interest Expense | -6.81 | -9.3 | -6.4 | -6.82 | -10.57 | Upgrade
|
| Interest & Investment Income | 1.56 | 1.66 | 0.33 | 0.34 | 0.22 | Upgrade
|
| Earnings From Equity Investments | 0.1 | -0.42 | 12.35 | 6.53 | 1.57 | Upgrade
|
| Other Non Operating Income (Expenses) | -3.75 | -1.41 | -3.88 | -1.08 | -10.07 | Upgrade
|
| EBT Excluding Unusual Items | -62.75 | -46.75 | -17.02 | 18.71 | 6.54 | Upgrade
|
| Asset Writedown | -4.5 | -12.97 | -0.59 | -0.19 | -0.13 | Upgrade
|
| Pretax Income | -67.25 | -59.72 | -17.61 | 18.52 | 6.41 | Upgrade
|
| Income Tax Expense | -2.23 | -2.83 | 1.63 | 4.31 | 3.25 | Upgrade
|
| Earnings From Continuing Operations | -65.02 | -56.89 | -19.24 | 14.2 | 3.16 | Upgrade
|
| Minority Interest in Earnings | 13.88 | 14.36 | 7.59 | -6.1 | -4.3 | Upgrade
|
| Net Income | -51.14 | -42.53 | -11.65 | 8.11 | -1.14 | Upgrade
|
| Net Income to Common | -51.14 | -42.53 | -11.65 | 8.11 | -1.14 | Upgrade
|
| Shares Outstanding (Basic) | 145 | 145 | 145 | 145 | 145 | Upgrade
|
| Shares Outstanding (Diluted) | 145 | 145 | 145 | 145 | 145 | Upgrade
|
| EPS (Basic) | -0.35 | -0.29 | -0.08 | 0.06 | -0.01 | Upgrade
|
| EPS (Diluted) | -0.35 | -0.29 | -0.08 | 0.06 | -0.01 | Upgrade
|
| Free Cash Flow | -32.39 | 11.36 | -22.91 | 28.19 | 45.15 | Upgrade
|
| Free Cash Flow Per Share | -0.22 | 0.08 | -0.16 | 0.20 | 0.31 | Upgrade
|
| Gross Margin | 38.48% | 41.21% | 44.06% | 39.21% | 41.23% | Upgrade
|
| Operating Margin | -29.22% | -14.17% | -6.72% | 5.29% | 7.29% | Upgrade
|
| Profit Margin | -27.75% | -16.17% | -4.03% | 2.17% | -0.33% | Upgrade
|
| Free Cash Flow Margin | -17.57% | 4.32% | -7.92% | 7.56% | 12.97% | Upgrade
|
| EBITDA | -38.14 | -22.7 | -2.35 | 40.92 | 49.93 | Upgrade
|
| EBITDA Margin | -20.69% | -8.63% | -0.81% | 10.97% | 14.34% | Upgrade
|
| D&A For EBITDA | 15.7 | 14.59 | 17.06 | 21.18 | 24.55 | Upgrade
|
| EBIT | -53.84 | -37.29 | -19.41 | 19.74 | 25.38 | Upgrade
|
| EBIT Margin | -29.22% | -14.17% | -6.72% | 5.29% | 7.29% | Upgrade
|
| Effective Tax Rate | - | - | - | 23.30% | 50.68% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.